Related Experiment Videos
The rational design of vaccine adjuvants for mucosal and neonatal immunization
1Mucosal Immunology Laboratory, Institute of Immunology, Biology Department, National University of Ireland Maynooth, Co., Kildare, Ireland. bpmahon@may.ie
Insights
Developing effective neonatal vaccines requires understanding mucosal and neonatal immunity. Recent advances enable rational design of novel adjuvants and delivery systems for targeted immune responses, overcoming challenges like maternal antibody interference.
Area of Science:
- Immunology
- Vaccinology
- Neonatal Health
Background:
- Urgent need for neonatal vaccines targeting mucosal surfaces (gut, respiratory tract).
- Development delayed by incomplete understanding of neonatal and mucosal immune systems.
- Advances in immunology provide insights into immune cell and molecule functions.
Purpose of the Study:
- Review recent advances in mucosal and neonatal immunity.
- Describe how T helper cell populations influence vaccine strategies.
- Discuss rational design of novel vaccine adjuvants and delivery systems.
Main Methods:
- Review of scientific literature on immunology, vaccinology, and neonatal immune responses.
- Analysis of T helper cell functions in vaccination.
- Categorization of adjuvants based on functional mechanisms.
- Discussion of DNA immunization and challenges in neonatal vaccination.
Main Results:
- Five functional classes of vaccine adjuvants identified, targeting antigen depot, conformation, immune cell targeting, mucosal responses, and cytotoxic T cell induction.
- Comparison of adjuvant properties between bacterial toxins and non-toxic derivatives.
- Exploration of DNA immunization's pros and cons.
- Identification of neonatal immune system immaturity and maternal antibodies as key challenges.
Conclusions:
- Novel vaccine adjuvants and delivery systems can be rationally designed for specific anatomical sites and T cell responses.
- Recent research indicates no intrinsic barrier to developing effective mucosal neonatal vaccines.
- Further research can overcome neonatal immune system limitations for successful vaccination.
Abstract:
There is an urgent requirement for neonatal vaccines that induce effective and long-lasting immune responses at the mucosal surfaces of the gut and respiratory tract. The delay in their development has been due in part to a lack of understanding of the mucosal and neonatal immune systems. This work reviews recent advances in the understanding of the cells and molecules that mediate immunity, describing the importance of different T helper populations in determining the success of vaccination strategies. These advances have allowed the rational design of novel vaccine adjuvants and delivery systems that can selectively induce immunity at different anatomical sites mediated by distinct T cell populations. Five functional classes of adjuvant are described. These exploit mechanisms which a) create an antigen depot, b) preserve antigen conformation, c) direct antigen to specific immune cells, d) induce mucosal responses and e) induce cytotoxic T cell responses. Comparisons are made between the chemical structures of bacterial toxins and non-toxic derivatives that retain adjuvanticity. The concept of DNA immunization is introduced and the advantages and disadvantages of this novel approach are discussed. The specific problems relating to neonatal immunization are explored with particular reference to the functional immaturity of the neonatal immune system and interference by maternal antibody. Finally, recent work suggesting that there is no intrinsic barrier to designing effective neonatal vaccines deliverable by the mucosal route is discussed.